2m 2m 2m 2m 2m 2m 2m
NOVAVAX (NVAX)
NASDAQ
$9.49+$0.07 (+0.75%)
Price as of Sep 11, 2026 7:59 PM EDT- $1.6BMarket Cap
- 18.05%1-Year Change
- BiotechnologyIndustry
NOVAVAX (NVAX)
$9.49+$0.07 (+0.75%)
Earnings Score
Valuation | NVAX | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -0 | ||
Growth | -0 | ||
Low Earnings Volatility | 2 |
Momentum Score
Valuation | NVAX | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | -8.19% | ||
12-Month Momentum | -3.86% | ||
3-Month Risk Adjusted Momentum | -46.94% | ||
12-Month Risk Adjusted Momentum | -6.26% |
True Yield
Valuation | NVAX | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | N/A | ||
Net Debt Paydown Yield | -0.03% |
Financial Health Score
Valuation | NVAX | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 5 |